Discover the top 3 evidence-based reasons people use medical cannabis: chronic pain, anxiety/PTSD, and sleep disorders, ...

Pizza just got an upgrade 😍🍕!! Missing skateboarder, 13, is found alive four days after vanishing - but bad news for his ...

An estimated 30 million Americans have sleep apnea, which is defined as recurring episodes of partial or complete airway ...

Doctor Ian Newberrry with RI ENT and Brown University Health was instrumental in bringing it here to RI in 2024.

Insights from analysts' 12-month price targets are revealed, presenting an average target of $289.62, a high estimate of $325 ...

GLP-1 drugs often cause weight loss because they mimic the GLP-1 hormone the body naturally produces after eating. Appetite ...

The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

Analysts are estimating that Inspire Medical Systems will report an earnings per share (EPS) of $0.21. Anticipation surrounds ...

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone ...

Resmed CEO Mick Farrell addressed the latest potential threats to the CPAP therapy market during a recent webcast: The ...

AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.